help button home button
AJRCCM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Reichman, L. B.
Right arrow Articles by Mangura, B. T.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Reichman, L. B.
Right arrow Articles by Mangura, B. T.
American Journal of Respiratory and Critical Care Medicine Vol 172. pp. 140, (2005)
© 2005 American Thoracic Society


Correspondence

And The Beat Goes On

To the Editor:

DOT Works and is Essential

DOT Works but is Obtrusive

DOT Doesn't Work

Ever since the directly observed therapy (DOT) strategy was endorsed by the World Health Organization (1), it has been a beacon of controversy.

Even though it is virtually intuitive that administering (the original term, although not immortalized by an acronym, was directly administered therapy) or observing drug taking ensures adherence, it has engendered controversy. The reasons behind the controversy, however, are not considered in Jasmer's analysis (2) or Burman and Reeves' editorial (3) essentially. DOT does not equal DOT, depending on the specific program. Zwarenstein (4), in an article considered the main detractor of DOT, reported 50% compliance with DOT, yet it is widely acknowledged that this was a poor program.

Recently, at the New Jersey Medical School National TB Center, we teased out exactly what component of the commonly used activities in TB control was most effective in curing patients (5). Employing a fortuitous stepwise change in program components over time, we showed in successive cohorts of patients using self-administration, self-administration with selective DOT, universal DOT alone, and DOT plus case management that only the addition of case management to DOT raised level of treatment completion and care from 50% to almost 90% (case management is an overarching system merging quality service with accountability for program performance) (6). The key concept is that observing medication taking along with accountability of staff for program components is the successful ingredient.

The San Francisco program as described (2) does not just observe patients, but does so in a meaningful, responsible manner (e.g., case management). It is time to ascribe its success to this modality combined with DOT. Simply put, case management is connecting the "dots" of a patient's journey through TB care from many different aspects: child care to social service to transportation and other medical services needed. Enablers and incentives in a program cannot happen by themselves: a responsible, accountable person needs to manage and coordinate these services for the patient.

Lee B. Reichman and Bonita T. Mangura

New Jersey Medical School National Tuberculosis Center, Newark, New Jersey

FOOTNOTES

Conflict of Interest Statement: L.B.R. does not have a financial relationship with a commercial entity that has an interest in the subject of this manuscript; B.T.M. does not have a financial relationship with a commercial entity that has an interest in the subject of this manuscript.

REFERENCES

  1. World Health Organization. Treatment of Tuberculosis: Guidelines for National Programmes, 2nd ed. Geneva, Switzerland; 1997. WHO/TB/97:220.
  2. Jasmer RM, Seaman CB, Gonzalez LC, Kawanura M, Osmond DH, Daley CL. Tuberculosis treatment outcomes: directly observed therapy compared with self-administered therapy. Am J Respir Crit Care Med 2004;170:561–566.[Abstract/Free Full Text]
  3. Burman WJ, Reves RR. How much directly observed therapy is enough? [editorial]. Am J Respir Crit Care Med 2004;170:474–475.[Free Full Text]
  4. Zwarenstein M, Shoeman JH, Vundule C, Lombard CJ, Tatley M. Randomized controlled trial of self-supervised and directly observed treatment of tuberculosis. Lancet 1998;352:1340–1343.[CrossRef][Medline]
  5. Mangura BT, Napolitano E, Passannante M, Sarrel M, McDonald R, Galanowsky KE, Reichman LB. Directly observed therapy (DOT) is not the entire answer: an operational cohort analysis. Int J Tuberc Lung Dis 2002;6:654–661.[Medline]
  6. Mangura BT, Galanowsky KE. Case management: the key to a successful tuberculosis control program. In Reichman LB, Hershfield EH, editors. Tuberculosis: a comprehensive international approach. New York: Marcel Dekker; 2000. pp. 597–608.




This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Reichman, L. B.
Right arrow Articles by Mangura, B. T.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Reichman, L. B.
Right arrow Articles by Mangura, B. T.


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Proc. Am. Thorac. Soc. Am. J. Respir. Cell Mol. Biol.
Copyright © 2005 American Thoracic Society